Opendata, web and dolomites

MetD-AO SIGNED

Methyl Donating artificial organelles to support liver cells in Non-alcoholic fatty liver disease

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 MetD-AO project word cloud

Explore the words cloud of the MetD-AO project. It provides you a very rough idea of what is the project "MetD-AO" about.

cholesterol    sized    career    function    poly    nano    aos    encompassing    multiple    cell    cargo    world    biocatalytic    employing    lysosome    consisting    compartment    assemble    me    homeostasis    fatty    methyl    chemist    perform    synth    deficiencies    acrylate    enzyme    disease    functional    methacrylate    medical    expertise    intracellular    metd    ao    adenosylmethionine    membranolytic    destroyed    lysosomal    structurally    reaction    self    nanoparticles    hepatocytes    trained    reactive    oxygen    escape    carboxypentyl    spectrum    assembly    failing    donating    cytosol    encapsulated    pharmaceutical    characterization    organic    western    copolymers    stadler    single    mimicking    organelles    few    latter    carrier    prospects    vitro    biology    damage    lost    chronic    dr    release    respectively    successful    started    liver    protein    amphiphilic    intact    biosynthesis    entirely    hydrophilic    complementary    therapeutic    reactors    host    nafld    science    synthetase    substitute    colloidal    reported    missing    cellular    tail    artificial    nonalcoholic    gaining    outcome    conduction    polymer    preserving    prior   

Project "MetD-AO" data sheet

The following table provides information about the project.

Coordinator
AARHUS UNIVERSITET 

Organization address
address: NORDRE RINGGADE 1
city: AARHUS C
postcode: 8000
website: www.au.dk

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 219˙312 €
 EC max contribution 219˙312 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2018
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2019
 Duration (year-month-day) from 2019-09-01   to  2021-08-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    AARHUS UNIVERSITET DK (AARHUS C) coordinator 219˙312.00

Map

 Project objective

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the Western world, encompassing a spectrum of liver damage. Multiple issues are involved on the cellular level in failing liver often including enzyme deficiencies such as reduced biosynthesis of S-adenosylmethionine (SAMe). Preserving SAMe homeostasis has only recently started to be considered as a potential therapeutic target in liver-related medical conditions. However, employing the required enzyme, SAMe synthetase (SAMe-synth), as a pharmaceutical, is challenging due to the general issues involved in intact (functional) protein delivery. The aim of the MetD-AO project is to assemble organic SAMe-synth activity mimicking polymer nanoparticles as artificial organelles (AO) and their in vitro characterization of intracellular function in hepatocytes. AOs are typically nano-sized single compartment reactors, aimed to perform a specific encapsulated biocatalytic reaction within a cell to substitute for missing or lost function. The AO will be based on amphiphilic copolymers consisting of a methyl-donating unit, cholesterol methacrylate and poly(5-carboxypentyl acrylate) as membranolytic hydrophilic tail. The latter two will aim at facilitating self-assembly and lysosomal escape, respectively. To allow structurally intact AO to escape the lysosome is unique since typically, the carrier is destroyed and only the therapeutic cargo is release into the cytosol. The proposed AOs with methyl-donating ability are highly advanced because the few prior reported AOs with intracellular activity all considered reactive oxygen related aspects at best. The successful outcome of MetD-AO has the potential to open up entirely new therapeutic opportunities in NAFLD. The complementary expertise of my host Dr. Stadler and me, a trained polymer chemist, will ensure a successful conduction of MetD-AO while it will enhance my future career prospects gaining experience in colloidal science and cell biology.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "METD-AO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "METD-AO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

THE CROSSMODAL BRAIN (2020)

Neural mechanisms of crossmodal activity in blind and sighted individuals

Read More  

TRANSCAMUS (2020)

NGOs, Transnational Networks and the Transformation of Muslim Communities in Cambodia

Read More  

SuperCoop (2019)

Unconventional Superconductivity and Strong Electron Correlations: a Cooperative mechanism

Read More